Additional file 3: Figure S2 a. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells
- Amani Moraya (4023536)
- Jennifer Ali (4023539)
- Pranati Samadder (2718055)
- Lisa Liang (4023542)
- Ludivine Morrison (4023551)
- Tamra Werbowetski-Ogilvie (4023548)
- Makanjuola Ogunsina (3758944)
- Frank Schweizer (148473)
- Gilbert Arthur (2274238)
- Mark Nachtigal (4023545)
Publication date
May 2017
DOIAbstract
Images of ovarian cancer cell clusters present in ascites fluid from patients EOC174 and EOC189. EOC174 had a larger number of cell clusters and larger clusters resembling spheroids. b. Representative images of EOC cells (A2780-cp cell line or primary cell samples EOC140 and EOC146) grown as adherent monolayers, non-adherent aggregates or spheroids at 2 and 7 days after seeding ultralow attachment plates. EOC140 are capable of forming spheroids by 7 days after seeding, whereas EOC146 formed numerous spheroid structures within 2 days
Add to ORKG